Current Ratio of Kymera Therapeutics, Inc. from 30 Jun 2021 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Kymera Therapeutics, Inc. quarterly Current Ratio in % history and change rate from 30 Jun 2021 to 31 Dec 2025.
  • Kymera Therapeutics, Inc. Current Ratio for the quarter ending 31 Dec 2025 was 872%, a 2.9% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Kymera Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q4 2025 872% +25% +2.9% 31 Dec 2025
Q3 2025 793% +40% +5.4% 30 Sep 2025
Q2 2025 822% +132% +19% 30 Jun 2025
Q1 2025 824% +168% +26% 31 Mar 2025
Q4 2024 848% +253% +43% 31 Dec 2024
Q3 2024 753% +119% +19% 30 Sep 2024
Q2 2024 690% +77% +13% 30 Jun 2024
Q1 2024 656% +102% +18% 31 Mar 2024
Q4 2023 595% +78% +15% 31 Dec 2023
Q3 2023 634% +139% +28% 30 Sep 2023
Q2 2023 613% +109% +22% 30 Jun 2023
Q1 2023 554% +88% +19% 31 Mar 2023
Q4 2022 517% +98% +23% 31 Dec 2022
Q3 2022 495% +129% +35% 30 Sep 2022
Q2 2022 504% +205% +69% 30 Jun 2022
Q1 2022 466% 31 Mar 2022
Q4 2021 419% 31 Dec 2021
Q3 2021 366% 30 Sep 2021
Q2 2021 299% 30 Jun 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.